Fast facts:
Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Schriftenreihe: | Fast facts
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 1910797308 1910797316 9781910797303 9781910797310 |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV048278756 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220610s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 1910797308 |q (electronic bk.) |9 1910797308 | ||
| 020 | |a 1910797316 |q (electronic bk.) |9 1910797316 | ||
| 020 | |a 9781910797303 |q (electronic bk.) |9 9781910797303 | ||
| 020 | |a 9781910797310 |q (electronic bk.) |9 9781910797310 | ||
| 035 | |a (OCoLC)967850096 | ||
| 035 | |a (DE-599)BVBBV048278756 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 100 | 1 | |a O'Brien, Mary |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Fast facts |c Mary O'Brien, Benjamin Besse |
| 246 | 1 | 3 | |a Non-small-cell lung cancer |
| 246 | 1 | 0 | |a Non-small-cell lung cancer |
| 264 | 0 | |a Abingdon, Oxford, UK |b Health Press |c 2016 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fast facts | |
| 505 | 8 | |a About the Authors; Copyright; Contents; Introduction; 1 Prevention and screening; Risk factors; Screening; Solitary peripheral nodules; 2 Diagnosis and pathological classification; Small biopsies and cytology specimens; Molecular testing for tumor gene (somatic) mutations; 3 Staging and surgery; TNM classification (IASLC, eighth edition); Surgical resection of early-stage NSCLC; Surgical resection of locally advanced NSCLC; 4 Radiotherapy; Patient selection; Radical radiotherapy delivery; Dose intensification; Postoperative radiotherapy; Palliative radiotherapy; 5 Immuno-oncology | |
| 505 | 8 | |a 8 Personalized treatment in advanced NSCLCEpidermal growth factor receptor mutation; Anaplastic lymphoma kinase gene rearrangement; Other actionable alterations in NSCLC; Useful resources; Index | |
| 505 | 8 | |a Mechanism of actionDrugs in development; Second-line monotherapy in NSCLC; First-line monotherapy in NSCLC; Adjuvant and neoadjuvant studies; Combination therapy with chemotherapy; Combination therapy with other checkpoint inhibition; Combination therapy with small molecule inhibitors; Combination therapy with radiotherapy; 6 First and second-line chemotherapy in advanced NSCLC; First-line chemotherapy; Chemotherapy in the elderly; Duration of chemotherapy; Maintenance therapy; Second-line chemotherapy; 7 Management of brain metastases; Diagnosis; Treatment options | |
| 520 | 3 | |a Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances | |
| 650 | 4 | |a Lung Neoplasms | |
| 650 | 7 | |a Poumons |2 Cancer | |
| 650 | 7 | |a HEALTH & FITNESS |2 Diseases | |
| 650 | 7 | |a Lungs |2 Cancer | |
| 650 | 7 | |a MEDICAL |2 Clinical Medicine | |
| 650 | 7 | |a MEDICAL |2 Diseases | |
| 650 | 7 | |a MEDICAL |2 Evidence-Based Medicine | |
| 650 | 7 | |a MEDICAL |2 Internal Medicine | |
| 650 | 4 | |a Lungs |x Cancer | |
| 653 | 6 | |a Electronic books | |
| 700 | 1 | |a Besse, Benjamin |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a O'Brien, Mary |t Fast Facts: Non-Small-Cell Lung Cancer |d Oxford : HEALTH PRESS LIMITED, ©2016 |z 9781910797198 |
| 856 | 4 | 0 | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1448882 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ZDB-4-EOAC | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033658921 | ||
Datensatz im Suchindex
| _version_ | 1804184102131204096 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | O'Brien, Mary |
| author_facet | O'Brien, Mary |
| author_role | aut |
| author_sort | O'Brien, Mary |
| author_variant | m o mo |
| building | Verbundindex |
| bvnumber | BV048278756 |
| collection | ZDB-4-EOAC |
| contents | About the Authors; Copyright; Contents; Introduction; 1 Prevention and screening; Risk factors; Screening; Solitary peripheral nodules; 2 Diagnosis and pathological classification; Small biopsies and cytology specimens; Molecular testing for tumor gene (somatic) mutations; 3 Staging and surgery; TNM classification (IASLC, eighth edition); Surgical resection of early-stage NSCLC; Surgical resection of locally advanced NSCLC; 4 Radiotherapy; Patient selection; Radical radiotherapy delivery; Dose intensification; Postoperative radiotherapy; Palliative radiotherapy; 5 Immuno-oncology 8 Personalized treatment in advanced NSCLCEpidermal growth factor receptor mutation; Anaplastic lymphoma kinase gene rearrangement; Other actionable alterations in NSCLC; Useful resources; Index Mechanism of actionDrugs in development; Second-line monotherapy in NSCLC; First-line monotherapy in NSCLC; Adjuvant and neoadjuvant studies; Combination therapy with chemotherapy; Combination therapy with other checkpoint inhibition; Combination therapy with small molecule inhibitors; Combination therapy with radiotherapy; 6 First and second-line chemotherapy in advanced NSCLC; First-line chemotherapy; Chemotherapy in the elderly; Duration of chemotherapy; Maintenance therapy; Second-line chemotherapy; 7 Management of brain metastases; Diagnosis; Treatment options |
| ctrlnum | (OCoLC)967850096 (DE-599)BVBBV048278756 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03399nmm a2200541 c 4500</leader><controlfield tag="001">BV048278756</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220610s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910797308</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">1910797308</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1910797316</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">1910797316</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797303</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9781910797303</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781910797310</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9781910797310</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)967850096</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048278756</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">O'Brien, Mary</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fast facts</subfield><subfield code="c">Mary O'Brien, Benjamin Besse</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Non-small-cell lung cancer</subfield></datafield><datafield tag="246" ind1="1" ind2="0"><subfield code="a">Non-small-cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="0"><subfield code="a">Abingdon, Oxford, UK</subfield><subfield code="b">Health Press</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fast facts</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">About the Authors; Copyright; Contents; Introduction; 1 Prevention and screening; Risk factors; Screening; Solitary peripheral nodules; 2 Diagnosis and pathological classification; Small biopsies and cytology specimens; Molecular testing for tumor gene (somatic) mutations; 3 Staging and surgery; TNM classification (IASLC, eighth edition); Surgical resection of early-stage NSCLC; Surgical resection of locally advanced NSCLC; 4 Radiotherapy; Patient selection; Radical radiotherapy delivery; Dose intensification; Postoperative radiotherapy; Palliative radiotherapy; 5 Immuno-oncology</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">8 Personalized treatment in advanced NSCLCEpidermal growth factor receptor mutation; Anaplastic lymphoma kinase gene rearrangement; Other actionable alterations in NSCLC; Useful resources; Index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Mechanism of actionDrugs in development; Second-line monotherapy in NSCLC; First-line monotherapy in NSCLC; Adjuvant and neoadjuvant studies; Combination therapy with chemotherapy; Combination therapy with other checkpoint inhibition; Combination therapy with small molecule inhibitors; Combination therapy with radiotherapy; 6 First and second-line chemotherapy in advanced NSCLC; First-line chemotherapy; Chemotherapy in the elderly; Duration of chemotherapy; Maintenance therapy; Second-line chemotherapy; 7 Management of brain metastases; Diagnosis; Treatment options</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lung Neoplasms</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Poumons</subfield><subfield code="2">Cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="2">Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lungs</subfield><subfield code="2">Cancer</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Clinical Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Evidence-Based Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="2">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lungs</subfield><subfield code="x">Cancer</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">Electronic books</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Besse, Benjamin</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">O'Brien, Mary</subfield><subfield code="t">Fast Facts: Non-Small-Cell Lung Cancer</subfield><subfield code="d">Oxford : HEALTH PRESS LIMITED, ©2016</subfield><subfield code="z">9781910797198</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1448882</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EOAC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033658921</subfield></datafield></record></collection> |
| id | DE-604.BV048278756 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T20:00:48Z |
| indexdate | 2024-07-10T09:34:00Z |
| institution | BVB |
| isbn | 1910797308 1910797316 9781910797303 9781910797310 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033658921 |
| oclc_num | 967850096 |
| open_access_boolean | 1 |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource |
| psigel | ZDB-4-EOAC |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| record_format | marc |
| series2 | Fast facts |
| spelling | O'Brien, Mary Verfasser aut Fast facts Mary O'Brien, Benjamin Besse Non-small-cell lung cancer Abingdon, Oxford, UK Health Press 2016 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Fast facts About the Authors; Copyright; Contents; Introduction; 1 Prevention and screening; Risk factors; Screening; Solitary peripheral nodules; 2 Diagnosis and pathological classification; Small biopsies and cytology specimens; Molecular testing for tumor gene (somatic) mutations; 3 Staging and surgery; TNM classification (IASLC, eighth edition); Surgical resection of early-stage NSCLC; Surgical resection of locally advanced NSCLC; 4 Radiotherapy; Patient selection; Radical radiotherapy delivery; Dose intensification; Postoperative radiotherapy; Palliative radiotherapy; 5 Immuno-oncology 8 Personalized treatment in advanced NSCLCEpidermal growth factor receptor mutation; Anaplastic lymphoma kinase gene rearrangement; Other actionable alterations in NSCLC; Useful resources; Index Mechanism of actionDrugs in development; Second-line monotherapy in NSCLC; First-line monotherapy in NSCLC; Adjuvant and neoadjuvant studies; Combination therapy with chemotherapy; Combination therapy with other checkpoint inhibition; Combination therapy with small molecule inhibitors; Combination therapy with radiotherapy; 6 First and second-line chemotherapy in advanced NSCLC; First-line chemotherapy; Chemotherapy in the elderly; Duration of chemotherapy; Maintenance therapy; Second-line chemotherapy; 7 Management of brain metastases; Diagnosis; Treatment options Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances Lung Neoplasms Poumons Cancer HEALTH & FITNESS Diseases Lungs Cancer MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine Electronic books Besse, Benjamin Sonstige oth Erscheint auch als Druck-Ausgabe O'Brien, Mary Fast Facts: Non-Small-Cell Lung Cancer Oxford : HEALTH PRESS LIMITED, ©2016 9781910797198 https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1448882 Verlag kostenfrei Volltext |
| spellingShingle | O'Brien, Mary Fast facts About the Authors; Copyright; Contents; Introduction; 1 Prevention and screening; Risk factors; Screening; Solitary peripheral nodules; 2 Diagnosis and pathological classification; Small biopsies and cytology specimens; Molecular testing for tumor gene (somatic) mutations; 3 Staging and surgery; TNM classification (IASLC, eighth edition); Surgical resection of early-stage NSCLC; Surgical resection of locally advanced NSCLC; 4 Radiotherapy; Patient selection; Radical radiotherapy delivery; Dose intensification; Postoperative radiotherapy; Palliative radiotherapy; 5 Immuno-oncology 8 Personalized treatment in advanced NSCLCEpidermal growth factor receptor mutation; Anaplastic lymphoma kinase gene rearrangement; Other actionable alterations in NSCLC; Useful resources; Index Mechanism of actionDrugs in development; Second-line monotherapy in NSCLC; First-line monotherapy in NSCLC; Adjuvant and neoadjuvant studies; Combination therapy with chemotherapy; Combination therapy with other checkpoint inhibition; Combination therapy with small molecule inhibitors; Combination therapy with radiotherapy; 6 First and second-line chemotherapy in advanced NSCLC; First-line chemotherapy; Chemotherapy in the elderly; Duration of chemotherapy; Maintenance therapy; Second-line chemotherapy; 7 Management of brain metastases; Diagnosis; Treatment options Lung Neoplasms Poumons Cancer HEALTH & FITNESS Diseases Lungs Cancer MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine |
| title | Fast facts |
| title_alt | Non-small-cell lung cancer |
| title_auth | Fast facts |
| title_exact_search | Fast facts |
| title_exact_search_txtP | Fast facts |
| title_full | Fast facts Mary O'Brien, Benjamin Besse |
| title_fullStr | Fast facts Mary O'Brien, Benjamin Besse |
| title_full_unstemmed | Fast facts Mary O'Brien, Benjamin Besse |
| title_short | Fast facts |
| title_sort | fast facts |
| topic | Lung Neoplasms Poumons Cancer HEALTH & FITNESS Diseases Lungs Cancer MEDICAL Clinical Medicine MEDICAL Diseases MEDICAL Evidence-Based Medicine MEDICAL Internal Medicine |
| topic_facet | Lung Neoplasms Poumons HEALTH & FITNESS Lungs MEDICAL Lungs Cancer |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1448882 |
| work_keys_str_mv | AT obrienmary fastfacts AT bessebenjamin fastfacts AT obrienmary nonsmallcelllungcancer AT bessebenjamin nonsmallcelllungcancer |